Literature DB >> 6159374

Demonstration of intracytoplasmic needle-like inclusions in hepatocytes of patients with porphyria cutanea tarda.

K R James, J M Cortés, F J Paradinas.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 6159374      PMCID: PMC1146259          DOI: 10.1136/jcp.33.9.899

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

Review 1.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

2.  Needle-like cytoplasmic inclusions in the liver in prophyria cutanea tarda.

Authors:  E D Waldo; H Tobias
Journal:  Arch Pathol       Date:  1973-12

3.  The ultrastructure of the liver in human symptomatic porphyria. A preliminary communication.

Authors:  A H Timme
Journal:  S Afr Med J       Date:  1971-09-25

4.  Properties and distribution of liver fluorescence in porphyria cutenua tarda (PCT).

Authors:  L Enerbäck; O Lundvall
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

5.  Chronic hepatic porphyria in chronic aggressive hepatitis.

Authors:  M Doss; D Look; H Henning
Journal:  Klin Wochenschr       Date:  1971-01
  5 in total
  3 in total

1.  The prevention of porphyrin loss from tissues during routine histological processing: quantitative studies on the Harderian gland.

Authors:  R C Spike; J McGadey; H S Johnston; A P Payne; G G Thompson; M R Moore
Journal:  Histochem J       Date:  1986-05

2.  Demonstration of needle-shaped hepatic inclusions in porphyria cutanea tarda using the ferric ferricyanide reduction test.

Authors:  F Fakan; A Chlumská
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Ferritin accumulation and uroporphyrin crystal formation in hepatocytes of C57BL/10 mice: a time-course study.

Authors:  P D Siersema; M I Cleton-Soeteman; W C de Bruijn; F J ten Kate; H G van Eijk; J H Wilson
Journal:  Cell Tissue Res       Date:  1993-11       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.